Dietary Supplement Legal Update - July 2018


Editors: Kevin M. Bell and Richard J. Oparil

The dietary supplement industry continues to confront legal and regulatory challenges. For additional information, contact Kevin Bell or Richard Oparil of Porzio's Washington, D.C. office. 

The recent significant developments in this Dietary Supplement Legal Update issue include: 

  • Senate Confirms New FTC Commissioners
  • SARMs Legislation Introduced 
  • Congressional Research Service Report On § 101 Patent Eligibility 
  • FDA Issues Warnings On Sunscreen Pills 
  • FDA Issues Warning Letters On Kratom Products Marketed For Opioid Cessation, Pain, And Other Medical Uses 
  • CBD Update 
  • Hemp Farming Legislation Passed By Senate 
  • Food Labeling Extension 
  • Bioengineered Labeling Rule 
  • Tariffs On Chinese Imports 
  • NAD Recommends Discontinuing Unsubstantiated Advertising Claims 
  • Consumer Fraud Claims Under New Jersey And Pennsylvania Statutes Survive Motion To Dismiss 
  • FDA Is Using New Methods To Prevent Illegal Products With Hidden Drug Ingredients From Entering The United States 
  • California Judge Issues Final Ruling Requiring Prop. 65 Warning Label on Brewed Coffee

To read the full issue, please click here.


Share with: